Mytiloxanthin

(2Z,4E,6E,8E,10E,12E,14E,16E)-3-hydroxy-19-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-1-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16-octaen-18-yn-1-one

WSLGBPCJDUQFND-BBPSKTQQSA-N CHEBI:186207 0 Reactome links 1 studies

Metabolite details

Identifier: WSLGBPCJDUQFND-BBPSKTQQSA-N
InChI Key: WSLGBPCJDUQFND-BBPSKTQQSA-N
IUPAC name: (2Z,4E,6E,8E,10E,12E,14E,16E)-3-hydroxy-19-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-1-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16-octaen-18-yn-1-one
Preferred name: Mytiloxanthin
INN name: —
Synonym: —
ChEBI: CHEBI:186207

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

G1_PBS_vs_G2_DSS